Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation.

Journal of drugs in dermatology : JDD

Volumn 12, Issue 3, 2013, Pages

  Makino, Elizabeth T T ^a   Mehta, Rahul C C ^b   Banga, Ajay ^b   Jain, Piyush ^b   Sigler, Monya L L ^b   Sonti, Sujatha ^b  

^a SkinMedica An Allergan Company   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; HYDROQUINONE; HYDROQUINONE DERIVATIVE; MELANIN;

ADULT; ARTICLE; BIOSYNTHESIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; ERYTHEMA; FEMALE; HUMAN; HYPERPIGMENTATION; INTRADERMAL DRUG ADMINISTRATION; MALE; METABOLISM; MIDDLE AGED; RADIATION EXPOSURE; RADIATION INJURY; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL; SKIN; TREATMENT OUTCOME; ULTRAVIOLET RADIATION;

ADMINISTRATION, CUTANEOUS; ADULT; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, RADIATION; DOUBLE-BLIND METHOD; ERYTHEMA; FEMALE; HUMANS; HYDROQUINONES; HYPERPIGMENTATION; MALE; MELANINS; MIDDLE AGED; RADIATION INJURIES; SKIN; TREATMENT OUTCOME; ULTRAVIOLET RAYS; YOUNG ADULT;

EID: 84884405447     PISSN: 15459616     EISSN: None     Source Type: None    
DOI: None     Document Type: Article

References (0)